PMDA drug package insert
ラコールNF配合経腸用半固形剤
PMDA Prescription drug · イーエヌ大塚製薬株式会社 · package insert May 16, 2022
Key facts
| Brand names | ラコールNF配合経腸用半固形剤 |
|---|---|
| Nonproprietary names | 経腸成分栄養剤 |
| Companies | 製造販売元／イーエヌ大塚製薬株式会社, 販売提携／大塚製薬株式会社, 販売提携／株式会社大塚製薬工場 |
| Product type | Prescription drug |
| Therapeutic category | たん白アミノ酸製剤 |
| Therapeutic category codes | 873259 |
| YJ codes | 3259118T1020 |
| Approval numbers | 22600AMX00523 |
| Package insert edition | 第1版 |
| Package insert date | May 16, 2022 |
| PMDA document key | 130589_3259118T1020_1 |
| PMDA company code | 130589 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: